S&P 500   2,990.72 (-0.24%)
DOW   26,849.53 (-0.65%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
BABA   170.36 (-3.67%)
TSLA   256.90 (-1.94%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
DIS   131.27 (-0.83%)
S&P 500   2,990.72 (-0.24%)
DOW   26,849.53 (-0.65%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
NVDA   190.73 (-1.83%)
BABA   170.36 (-3.67%)
TSLA   256.90 (-1.94%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
DIS   131.27 (-0.83%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Allogene TherapeuticsChina Biologic ProductsAblynxRepligenIovance Biotherapeutics
SymbolNASDAQ:ALLONASDAQ:CBPON/ANASDAQ:RGENNASDAQ:IOVA
Price Information
Current Price$27.30$116.30N/A$78.69$19.55
52 Week RangeBuyHoldN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldN/ABuyBuy
Consensus Price Target$36.22$78.00N/A$100.71$30.80
% Upside from Price Target32.68% upside-32.93% downsideN/A27.99% upside57.54% upside
Trade Information
Market Cap$3.17 billion$4.56 billion$3.81 billion$4.08 billion$2.41 billion
BetaN/A1.21.991.141.91
Average Volume506,471244,040N/A902,4721,552,092
Sales & Book Value
Annual RevenueN/A$466.88 million$62.73 million$194.03 millionN/A
Price / SalesN/A9.800.0020.90N/A
CashflowN/A$5.14 per shareN/A$1.11 per shareN/A
Price / CashN/A22.61N/A70.75N/A
Book Value$5.79 per share$55.68 per share$2.71 per share$14.03 per share$3.78 per share
Price / BookN/A2.090.005.61N/A
Profitability
Net Income$-211,510,000.00$128.06 million$-122,670,000.00$16.62 million$-123,580,000.00
EPS($6.58)$4.02N/A$0.73($1.27)
Trailing P/E RatioN/A28.930.00107.79N/A
Forward P/E RatioN/A30.85N/A71.54N/A
P/E GrowthN/A$7.02N/A$4.65N/A
Net MarginsN/A29.46%N/A11.42%N/A
Return on Equity (ROE)-31.00%8.56%N/A6.92%-38.88%
Return on Assets (ROA)-21.55%7.86%N/A5.54%-36.60%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%N/AN/A0.02%0.01%
Current Ratio13.46%10.57%N/A2.25%12.15%
Quick Ratio13.46%8.62%N/A1.88%12.14%
Ownership Information
Institutional Ownership Percentage55.97%36.90%N/A86.59%98.80%
Insider Ownership Percentage36.50%2.73%N/A1.70%9.30%
Miscellaneous
Employees1222,187N/A54888
Shares Outstanding121.75 million39.36 million75.25 million51.53 million123.83 million
Next Earnings Date11/6/2019 (Estimated)11/7/2019 (Estimated)N/A11/7/2019 (Estimated)11/5/2019 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableOptionable
 Allogene TherapeuticsChina Biologic ProductsAblynxRepligenIovance Biotherapeutics

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel